Carboplatin in advanced hormone refractory prostatic cancer patients
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (15), 2094-2096
- https://doi.org/10.1016/0959-8049(93)90040-m
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group StudyEuropean Journal Of Cancer, 1992
- Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracilCancer, 1992
- Carboplatin: current status and future prospectsCancer Treatment Reviews, 1988
- Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?Journal of Clinical Oncology, 1985
- A reexamination of the stable category for evaluating response in patients with advanced prostate cancerCancer, 1984
- Phase II study of cisplatin for metastatic prostatic carcinomaAmerican Journal of Clinical Oncology, 1983
- Systemic Treatment of Advanced Prostatic Cancer: Development of a New System for Defining ResponseJournal of Urology, 1981
- Reporting results of cancer treatmentCancer, 1981
- Prostatic CarcinomaNew England Journal of Medicine, 1979
- Chemotherapy of advanced prostatic cancer Evaluation of response parametersUrology, 1976